Summary
Three metabolites of mebendazole were isolated from the bile of rats dosed with a mixture of mebendazole and pentadeutero-mebendazole. The identification was based upon the appearance of the characteristic doublet in the mass spectrum of the compounds and the comparison of their fragmentations with those of authentic compounds. Cochromatography of the metabolites with the authentic compounds on HPLC supported the identification. Methyl-5(6)-(α-hydroxybenzyl)-2-benzimidazole carbamate, 2-amino-5(6)-(α-hydroxybenzyl) benzimidazole and 2-amino-5(6)-benzoylbenzimidazole were identified as metabolites after enzymic conjugate hydrolysis. Some unmetabolized mebendazole was also found.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brugmans, J.P., Thienpont, D.C., van Wijngaarden, I., Vanparijs, D.F., Schuermans, V.L. and Lauwers, H.L. (1971). Mebendazole in enterobiasis: Radiochemical and pilot clinical study in 1,278 subjects. J. Amer. Med. Assoc.217, 313–316.
Goodman, H.T. (1976). Mebendazole. Med. J. Aust.2, 662.
Bekhti, A., Schaaps, J.-P., Capron, M., Dessaint, J.-P., Santoro. F. and Capron, A. (1977). Treatment of hepatic hydatid disease with mebendazole: preliminary results in four cases. Brit. Med. J.2, 1047–1051.
Wilson, J.F., Davidson, M. and Rausch, R.L. (1978). A clinical trial of mebendazole in the treatment of alveolar hydatid disease. Amer. Rev. Resp. Dis.118. 747–757.
Al-Moslih, M.I., Al-Janabi, T.A., Al-Rawas, A.Y., Shafik, M.A., Rassam, S., Al-Ani, M.S. and Al-Dabagh, M.A. (1978). Treatment of hydatidosis. Brit. Med. J.2, 1435.
Kern, P., Dietrich, M. and Volkmer, K.-J. (1979). Chemotherapy of echinococcosis with mebendazole: clinical observations of 7 patients. Troponmed. Parasitol.30, 65–72.
Meuldermans, W.E.G., Hurkmans, R.M.A., Lauwers, W.F.J., and Heykants, J.J.P. (1976). Thein vitro metabolism of mebendazole by pig, rat and dog liver fractions. Eur. J. Drug Metab. Pharmacokinetics1, 35–40.
Allan, R.J., Goodman, H.T. and Watson, T.R. (1980). Two high performance liquid chromatographic determinations for mebendazole and its metabolites in human plasma using a rapid Sep Pak C18 extraction. J. Chromatogr.183, 311–319.
Tocco, D.J., Buhs, R.P., Brown, H.D., Matzuk, A.R., Mertel, H.E., Harman, R.E. and Trenner, N.R. (1964). The metabolic fate of thiabendazole in sheep. J. Med. Chem.7, 399–405.
Douch, P.G.C. (1973). The metabolism of benomyl fungicide in mammals. Xenobiotica3, 367–380.
Gardiner, J.A., Kirkland, J.J., Klopping, H.L. and Sherman, H. (1974). Fate of benomyl in animals. J. Agr. Food Chem.22, 419–427.
Tyler, T.R., Lee, J.T., Flynn, H. and Vanden Heuvel, W.J.A. (1976). Identification of 5-hydroxybenzimidazole as major urinary metabolite of benzimidazole in the rat. Drug Metab. Disposition4, 177–179.
Bell, J.P. and Tomlinson, R.V. (1976). Metabolites of a new anthelmintic agent, oxfendazole. Fed. Proc.35, 487.
Mayo, B.C., Brodie, R.R., Chasseaud, L.F. and Hawkins, D.R. (1978). Biotransformation of methyl 5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) in rats and dogs. Drug. Metab. Disposition6, 518–527.
Dunn, G.L., Gallagher, G., Jr., Davis, L.D., Hoover, J.R.E. and Stedman, R.J. (1973). Metabolites of methyl 5(6)-butyl-2-benzimidazole carbamate (Parbendazole). Structure and synthesis. J. Med. Chem.16, 966–1002.
Di Cuollo, C.J., Miller, J.A., Mendelson, W.L. and Pagano, J.F. (1974). Metabolic and tissue residue studies on parbendazole in sheep. J. Agr. Food Chem.22, 948–953.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Allan, R.J., Watson, T.R. Identification of biliary metabolites of Mebendazole in the rat. European Journal of Drug Metabolism and Pharmacokinetics 7, 131–136 (1982). https://doi.org/10.1007/BF03188730
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03188730